---
title: "Rite Zone Chemcon India Ltd (RITEZONE) — Share Price, Financials & Analysis"
symbol: "RITEZONE"
company: "Rite Zone Chemcon India Ltd"
canonical: "https://tapetide.com/stocks/RITEZONE"
isin: "INE0MRA01019"
nse_symbol: "RITEZONE"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 9.54
generated_at: "2026-09-13T18:37:10.192Z"
---

# Rite Zone Chemcon India Ltd (RITEZONE)

Canonical page: https://tapetide.com/stocks/RITEZONE

## Company

- **NSE Symbol:** RITEZONE
- **ISIN:** INE0MRA01019
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2022-11-11
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ritezone.in

## About

Incorporated in 2015, Rite Zone Chemcon India Ltd trades chemical products for civil construction, pre- / post-construction buildings /structures and Infrastructure[1]

## Latest Price

- **Price:** ₹21.45
- **Change:** -1.1 (-4.88%)
- **Open:** ₹21.45
- **Day High:** ₹21.45
- **Day Low:** ₹21.45
- **Previous Close:** ₹22.55
- **Volume:** 1600
- **As Of:** 2026-09-11T05:01:52+00:00

## Key Fundamentals

Observed at 2026-09-11T04:50:01.351345Z.

- **Market Cap:** ₹9.54 Cr
- **Classification:** SME
- **P/E (reported):** 27.8
- **Book Value:** ₹36.46
- **Price to Book:** 0.62
- **Dividend Yield:** 0%
- **ROE:** 2.21%
- **ROCE:** 4.16%
- **Debt to Equity:** 0.1
- **Revenue (yearly):** ₹25.8 Cr
- **Net Income:** ₹0.3 Cr
- **EBITDA:** ₹0.9 Cr
- **52-Week High:** ₹36.55
- **52-Week Low:** ₹13.8
- **RSI (14):** 63.9

## Key Insights

### Strengths

- Stock is trading at 0.59 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.42% over last 3 years.
- Company has high debtors of 188 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | — | 226.92% | 118.23% |
| ebitda margin growth | -34.43% | -45.78% | -76.16% |
| net income growth | -66.67% | -26% | 102% |
| revenue growth | -2.27% | 4% | 46% |
| roce | -44.31% | -59.01% | 8.1% |
| roe | -62.67% | 5.37% | -51.64% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2.45 | 10.34 | 12.12 | 10.81 | 15.92 | 14.26 | 11.94 | 11.75 | 13.79 |
| Expenses | 2.58 | 9.81 | 11.22 | 10.11 | 15 | 13.4 | 11.57 | 11.4 | 13.48 |
| Operating Profit | -0.13 | 0.53 | 0.9 | 0.7 | 0.92 | 0.86 | 0.37 | 0.35 | 0.31 |
| OPM % | -5.31 | 5.13 | 7.43 | 6.48 | 5.78 | 6.03 | 3.1 | 2.98 | 2.25 |
| Other Income | 0.53 | 0.02 | 0 | 0.05 | 0.11 | 0.03 | 0.19 | 0.08 | 0.19 |
| Interest | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.07 |
| Depreciation | 0.12 | 0.18 | 0.08 | 0.13 | 0.14 | 0.12 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 0.23 | 0.32 | 0.77 | 0.58 | 0.86 | 0.74 | 0.38 | 0.27 | 0.3 |
| Tax % | 56.52 | 43.75 | 15.58 | 32.76 | 16.28 | 17.57 | 28.95 | 33.33 | 43.33 |
| Net Profit | 0.1 | 0.17 | 0.66 | 0.4 | 0.73 | 0.62 | 0.28 | 0.18 | 0.16 |
| EPS in Rs | 0.33 | 0.56 | 1.56 | 0.95 | 1.73 | 1.47 | 0.66 | 0.43 | 0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 5.75 | 3.8 | 4.93 | 22.46 | 26.72 | 26.2 | 25.54 |
| Expenses | 5.2 | 3.53 | 4.8 | 21.04 | 25.1 | 24.97 | 24.88 |
| Operating Profit | 0.55 | 0.27 | 0.13 | 1.42 | 1.62 | 1.23 | 0.66 |
| OPM % | 9.57 | 7.11 | 2.64 | 6.32 | 6.06 | 4.69 | 2.58 |
| Other Income | -0.08 | 0.04 | 0.71 | 0.03 | 0.16 | 0.22 | 0.27 |
| Interest | 0.14 | 0.12 | 0.1 | 0.1 | 0.07 | 0.07 | 0.11 |
| Depreciation | 0.21 | 0.18 | 0.23 | 0.26 | 0.26 | 0.25 | 0.25 |
| Profit before tax | 0.12 | 0.01 | 0.51 | 1.09 | 1.45 | 1.13 | 0.57 |
| Tax % | -33.33 | 100 | 54.9 | 23.85 | 22.07 | 20.35 | 38.6 |
| Net Profit | 0.16 | 0.01 | 0.23 | 0.83 | 1.13 | 0.89 | 0.34 |
| EPS in Rs | 160 | 10 | 0.76 | 1.96 | 2.67 | 2.1 | 0.8 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 3.04 | 4.23 | 4.23 | 4.23 | 4.23 |
| Reserves | 0.62 | 0.62 | 1.98 | 8.83 | 9.96 | 10.85 | 11.19 |
| Borrowings | 2.59 | 3.29 | 1.06 | 0.93 | 0.8 | 0.95 | 1.59 |
| Other Liabilities | 3.45 | 2.86 | 5.16 | 5.19 | 4.76 | 5.5 | 5.63 |
| Total Liabilities | 6.67 | 6.78 | 11.24 | 19.18 | 19.75 | 21.53 | 22.64 |
| Fixed Assets | 1.37 | 2.13 | 2.09 | 1.87 | 1.78 | 1.84 | 1.73 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2.37 | 2.45 |
| Other Assets | 5.3 | 4.65 | 9.15 | 17.31 | 17.97 | 17.32 | 18.46 |
| Total Assets | 6.67 | 6.78 | 11.24 | 19.18 | 19.75 | 21.53 | 22.64 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.27 | 1.09 | -3.62 | -3.86 | -0.52 | -0.06 | 0.66 |
| Cash from Investing Activity | 0.32 | -0.93 | -0.19 | -0.04 | -0.17 | -0.22 | -0.23 |
| Cash from Financing Activity | -0.14 | -0.12 | 4.02 | 7.11 | -0.16 | 0.1 | -0.07 |
| Net Cash Flow | -0.09 | 0.04 | 0.21 | 3.2 | -0.85 | -0.18 | 0.36 |
| Free Cash Flow | 0.05 | 0.16 | -3.81 | -3.9 | -0.69 | -0.37 | 0.51 |
| CFO/OP | -40 | 407 | -2662 | -253 | -9 | 18 | 135 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 323.1 | 421.67 | 639.68 | 155.36 | 150.4 | 176.65 | 188.5 |
| Inventory Days | 0 | 0 | 0 | 1.85 | 0.71 | 1.27 | 1.67 |
| Days Payable | — | — | — | 90.43 | 76.09 | 88.2 | 93.76 |
| Cash Conversion Cycle | 323.1 | 421.67 | 639.68 | 66.79 | 75.02 | 89.72 | 96.42 |
| Working Capital Days | 92.04 | 144.08 | 261.35 | 135.21 | 140.43 | 160.21 | 164.92 |
| ROCE % | — | 3.64 | 12.4 | 11.86 | 10.49 | 7.74 | 4.12 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% | 41.89% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 40.85% | 41.04% | 40.62% | 46.71% | 46.52% | 46.71% | 46.45% | 47.96% | 48.38% | 48.45% | 46.83% |
| Others | 17.26% | 17.07% | 17.48% | 11.39% | 11.58% | 11.39% | 11.66% | 10.15% | 9.73% | 9.65% | 11.28% |
| No. of Shareholders | 421 | 423 | 449 | 642 | 611 | 599 | 582 | 587 | 563 | 542 | 520 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 4 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 19.93 | Buy |
| EMA (10) | 20.62 | Buy |
| SMA (20) | 19.34 | Buy |
| EMA (20) | 20.07 | Buy |
| SMA (50) | 20.24 | Buy |
| EMA (50) | 20.14 | Buy |
| SMA (100) | 20.46 | Buy |
| EMA (100) | 20.92 | Buy |
| SMA (200) | 22.62 | Sell |
| EMA (200) | 23.88 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 56.97 | Neutral |
| MACD (12,26,9) | 0.43 | Buy |
| Stochastic (14,3,3) | 93.68 | Sell |
| ADX (14) | 12.68 | Neutral |
| Williams %R (14) | -18.97 | Sell |
| ATR (14) | 1 | High Volatility |
| ROC (12) | 17.53 | Buy |
| Stoch RSI (14) | 74.45 | Neutral |
| UO (7,14,28) | 77.34 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 January 2026 - Certificate from RTA per Regulation 74(5) for quarter ended December 31, 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 January 2026 - Certificate from RTA per Regulation 74(5) for quarter ended December 31, 2025.](https://nsearchives.nseindia.com/corporate/RITEZONE_09012026123942_74_RZ.pdf) |
| 8 Sep - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … | [Price movement 8 Sep - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …](https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=RITEZONE&tabIndex=sme) |
| 5 May 2026 - Quarterly SDD compliance certificate for March 31, 2026; no noncompliance reported. | [Structural Digital Database 5 May 2026 - Quarterly SDD compliance certificate for March 31, 2026; no noncompliance reported.](https://nsearchives.nseindia.com/corporate/RITEZONE_05052026125550_SDD_march_26.pdf) |
| 31 Aug - Rite Zone Chemcon India Limited has informed about Resignation of Statutory Auditor | [Resignation of Statutory Auditor 31 Aug - Rite Zone Chemcon India Limited has informed about Resignation of Statutory Auditor](https://nsearchives.nseindia.com/corporate/RITEZONE_ROSA_97448_KMP_Doc.zip) |
| 31 Aug - Kumbhat & Co. LLP resigned as statutory auditor on Aug. 31, 2026 over audit fee disagreement. | [Change in Auditors 31 Aug - Kumbhat & Co. LLP resigned as statutory auditor on Aug. 31, 2026 over audit fee disagreement.](https://nsearchives.nseindia.com/corporate/RITEZONE_31082026161825_Change_of_Auditor_Intimation_with_Resignation_letter.pdf) |
| 24 March 2026 - Trading window closed Apr 01, 2026 until 48 hours after audited results for period ended Mar 31, 2026. | [Trading Window 24 March 2026 - Trading window closed Apr 01, 2026 until 48 hours after audited results for period ended Mar 31, 2026.](https://nsearchives.nseindia.com/corporate/RITEZONE_24032026163404_Trading_WIndow.pdf) |
| 24 Jun - Board approved HDFC Bank credit facilities up to Rs 5 crore and appointed internal auditor for FY27. | [Outcome of Board Meeting 24 Jun - Board approved HDFC Bank credit facilities up to Rs 5 crore and appointed internal auditor for FY27.](https://nsearchives.nseindia.com/corporate/RITEZONE_24062026172050_Ritezone_Outcome.pdf) |
| 23 April 2026 - On April 22, 2026, company said Annual Secretarial Compliance Report is not applicable under SME rules. | [Updates 23 April 2026 - On April 22, 2026, company said Annual Secretarial Compliance Report is not applicable under SME rules.](https://nsearchives.nseindia.com/corporate/RITEZONE_23042026135001_RZ_Non_applicability_24A.pdf) |
| 22 Jun - Rite Zone Chemcon India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and … | [Disclosure under SEBI Takeover Regulations 22 Jun - Rite Zone Chemcon India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and …](https://nsearchives.nseindia.com/corporate/team_sandeshc_13052026123636_25.pdf) |
| 22 April 2026 - On April 21, 2026, Rite Zone confirmed FY27 large corporate disclosure is not applicable. | [Updates 22 April 2026 - On April 21, 2026, Rite Zone confirmed FY27 large corporate disclosure is not applicable.](https://nsearchives.nseindia.com/corporate/RITEZONE_22042026123212_RZ_Large_Corporate_Disclosure.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31180_RITEZONE_2025_2026_A_2289731_02092026221111.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28376_RITEZONE_2024_2025_A_2341825_03092025222044.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26230_RITEZONE_2023_2024_10092024175633.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23458_RITEZONE_2022_2023_04092023220653_09052023070010.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:10.192Z.